Naloxegol clinical trials
Also written NKTR-118.
How each study uses naloxegol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 7 Dec 2014 · Moventig · EMEA/H/C/002810 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
33 studies that test it; most in 2011 (11); 1 more planned to start later
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2011 | 11 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 19 · Other 15
AstraZeneca (18) · Massachusetts General Hospital (2) · Temple University (2) · CMC Ambroise Paré (1) · University of Missouri-Columbia (1) · Kyowa Kirin Pharmaceutical Development Ltd (1) · The Cleveland Clinic (1) · Universitaire Ziekenhuizen KU Leuven (1)
Often tested with
Tested in the same studies.
Methylnaltrexone (1) · Codeine (1) · Polyethylene glycol 3350 (1)
Related medicines
As reviewed, each with the page that says it.
- One of Opioid antagonists source
Studies
Open first, then newest update. How each study uses naloxegol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 34
- Evaluation of Naloxegol in the Prevention of POI After CystectomyWithdrawnPhase 2Institut Paoli-CalmettesNCT04219046Written as Naloxégol oxalateHow we know
- The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtientsSuspendedPhase 3University Hospital, BrestNCT05008926Written as NaloxegolHow we know
- Effect of Naloxegol on Postoperative Ileus in Patients Undergoing Cardiac SurgeryCompletedPhase 3CMC Ambroise ParéNCT04433390Written as NaloxegolHow we know
- Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerTerminatedPhase 2Alliance for Clinical Trials in OncologyNCT03087708Written as NaloxegolHow we know
- Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced ConstipationCompletedPhase 4University of Missouri-ColumbiaNCT03523520Written as Naloxegol 25 MG Oral TabletHow we know
- Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC PatientsCompletedPhase 1Kyowa Kirin Pharmaceutical Development LtdNCT02099591Written as NaloxegolHow we know
- Ancillary Effects of Oral Naloxegol (Movantik)CompletedPhase 4The Cleveland ClinicNCT03235739Written as Naloxegol 25 MGHow we know
- Colonic Motor Patterns in Healthy VolunteersCompletedPhase 4Universitaire Ziekenhuizen KU LeuvenNCT05770960Written as NaloxegolHow we know
- Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered OpioidsTerminatedPhase 4Tufts Medical CenterNCT02977286Written as Naloxegol Oral TabletHow we know
- Naloxegol and Opioid-induced ConstipationStatus unknownPhase 2/3TriHealth Inc.NCT03316859Written as Naloxegol 25 MGHow we know
- The Effect of Naloxegol on Refractory Constipation in the Intensive Care UnitWithdrawnPhase 3Massachusetts General HospitalNCT02705378Written as naloxegolHow we know
- Naloxegol for Opioid-Related GastroparesisWithdrawnPhase 2Temple UniversityNCT03036891Written as Naloxegol 25 MG Oral Tablet [Movantik]How we know
- Naloxegol in Cancer Opioid-Induced ConstipationTerminatedPhase 2Joseph MaNCT02745353Written as naloxegolHow we know
- Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery PatientsTerminatedPhase 4Massachusetts General HospitalNCT02946580Written as MOVANTIK™ (naloxegol)How we know
- Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)TerminatedPhase 4Hospice of Henderson County, Inc.NCT02839889Written as NaloxegolHow we know
- Movantik for Opioid-Related Esophageal DisordersTerminatedPhase 2Temple UniversityNCT02998606Written as NaloxegolHow we know
- To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced ConstipationCompletedPhase 4AstraZenecaNCT03060512Written as MovantikHow we know
- A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and SolutionCompletedPhase 1AstraZenecaNCT02446171Written as Naloxegol 25 mg tablet, crushed, suspended in water, given orallyHow we know
- A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCompletedPhase 3AstraZenecaNCT01395524Written as NKTR-118How we know
- A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)CompletedPhase 2AstraZenecaNCT00600119Written as NKTR-118How we know
Codes
What other systems call naloxegol · ClinicalTrials.gg INT000023
- MeSH (NLM) C000589308naloxegolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 44T7335BKENALOXEGOLConfirmed FDA, NLM, Wikidata
- RxNorm 1551777Confirmed FDA, Wikidata
- Wikidata Q15708351naloxegolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C97506NaloxegolOne source FDA
- DrugBank DB09049One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000589308 | naloxegol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 44T7335BKE | NALOXEGOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1551777 | — | Confirmed FDA, Wikidata |
| Wikidata | Q15708351 | naloxegol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C97506 | Naloxegol | One source FDA |
| DrugBank | DB09049 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.